New vaccine hope for blood cancer patients after transplant

NCT ID NCT04977024

First seen Feb 11, 2026 · Last updated May 13, 2026 · Updated 13 times

Summary

This study is for people with blood cancers like leukemia or lymphoma who have had a stem cell transplant or cell therapy. It tests a new COVID-19 vaccine (GEO-CM04S1) to see if it provides better protection against COVID-19 than the standard mRNA vaccines. The goal is to help these patients, who often have weaker immune systems, avoid serious COVID-19 illness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina, 27157, United States

  • City of Hope Medical Center

    Duarte, California, 91010, United States

  • Fred Hutchinson Cancer Center

    Seattle, Washington, 98109, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21205, United States

  • SUNY-Stony Brook

    Stony Brook, New York, 11794, United States

  • U Mass Chan Medical School

    Worcester, Massachusetts, 01655, United States

Conditions

Explore the condition pages connected to this study.